$NWBO Tale of the Tape today, 7.5 million on volume, up 10.42 percent. For Daily we need to close above .18 and on Weekly we need to do the same. Have not closed above the 20MA on Weekly since May when we were about .30 cents briefly. I will be looking for Volume to pick up if we get closer to a MHRA decision, Thursday OCT 29th is next CHM meeting which we are hoping a decision is made and sometime in November announcement is given.

Interesting Stephen Moore himself wrote the Column for Maui News himself, he contributes to local publications in Hawaii it seems.

@StephenMoore @realDonaldTrump @POTUS @DrOzCMS This needs addressed immediately @NorthwestBio $NWBO @AlMusella

ct, not so sure with new PR Employee restructuring. Seems full steam ahead, November looks promising

$NWBO As most heard George Zavoico departure as Vice President of Corporate Development over a week ago comes as we now we see the new PR today by Northwest Bio. I really appreicated all the effort and communication George had put into the company especially spear heading the relationship with the CVC "Cancer Vaccine Coalition" group. He did alot of work unknown to the general public that help build corporate relationships for NWBO. prnewswire.com/news-releases…

Explains George Zavoico release from the company

$NWBO Seems @StephenMoore addressed @HollensbeAmanda Braelyn this morning on Fox Business. Here is an article in Maui News which looks to be the same content. mauinews.com/opinion/columns… "Every few months, a young 19-year-old woman from South Carolina boards a plane to London. She isn’t going sightseeing. She’s going to get her next dose of a cancer treatment that was invented in the United States, developed by an American company, and credited by her doctors with clearing a brain tumor other surgeons had refused to touch. She was diagnosed with glioblastoma at 16. It is the most common and most lethal brain cancer, the disease that killed John McCain and Beau Biden. Her tumor came back so aggressively after her first surgery that doctors stopped operating. This was a death sentence."

$NWBO Is it possible my well aged special labeled wine finally gets Opened in November 2026 or will the bottle continue to age? She will be opened on first approval and celebrated regardless of where SP lands.

$NWBO I decided to another look at August CHM meeting minutes of the Members attending and special invitees. My interest was getting additional intel on NHSBT Collaboration in OCT and if any members exist on CHM that would provide additional context that NHSBT is well aware of CHM/MHRA discussions and progress on approval. This is my own DD, so you can make your own conclusions etc. Marc Turner is Member of CHM, Director of the Scottish National Blood Transfusion Service (SNBTS) and is Chair of the Vaccine Expert Advisory Group BVEAG. He did not attend the August Meeting, but most likely attended the all critical SEPT meeting. SNBTS and NHSBT cooperate through the UK Blood Services Forum and other joint activities. Turner has historically participated in UK-wide blood-services governance alongside NHSBT leadership. The special invitee was Professor Farzin Farzaneh who knows all about DCVAX as seen in Image.

That NHSBT IMO knows for sure status of MHRA application before Collaboration agreement in OCT with NWBO.

3rd Image cutoff but news sent to me today but posted in Rueters on 23rd....

$NWBO I get all alerts for DCVAX, first time ever I got a alert of Reuters, The I/B/E/S Buy rating of Outperform posted yesterday, Reuters for NWBO comes from financial data associated with LSEG, London Stock Exchange Group. Most all of my alerts come from news like in the 3rd image attached. Probably nothing but noted anyway.

Do not know what to tell you with that, the recent findings are valid and we have not seen that for 3 years, we all want a decision like ages ago, you are not in that boat alone.

Tony, just putting some feasable timelines based on visual facts we see, that is it, you take it as you will. Yes we could get pushed out, but everything has a end date including NWBO

Before open on a Monday, give a week to release other news to crush the shorts, that is if Linda plays her cards right.

$NWBO @NorthwestBio As we now head into the weekend and November nears we now know via the CHM minutes for August 2026 "A medicine used to treat glioblastoma cancer of the brain" was mentioned in the Pre-Hearing section indicating an Oral meeting will be needed to decide whether the data have resolved the questions put to the NorthWest Bio. Based on history and language used in past CHM minutes, specifically in May of 2024 where Eli Lilly was informed for an Oral meeting and then in July the meeting was held resulting in a decision and approval in August of 2024 two months after the Pre-Hearing paragraph on the alzheimer's drug. Will DCVAX-L follow the same timelines ? That is the question or will MHRA ask for even more answers that can't be resolved in meeting. We do not know for sure Oral meeting happened in Sept, but if it did, OCT meeting should be the decision and possible approval for Nov 2026. These are all if's but I believe the timelines are feasable and just maybe we are at the END of the ROAD.

Not both drugs that were approved for alzheimer's back in August/October 2024 were under same company Eli Lilly, CHM meeting minutes does not differentiate between the two, so really the approval could be stated in happened once in 2024 not twice as shown on Image. Kind of confusing, but PDF spells it out a little better.

Tommy, yes likely Sept with possible outcome in Meeting coming up for OCT, that would only if no new concerns arise, all SEPT is not official yet either so we dont know. I mean it could have skipped SEPT if NWBO was not ready to provide ORAL meeting.

Well as you see we had approvals on some with same verbage context, CHM wanting ORAL meeting does not mean doom and gloom as some may want to lean that way, DCVAX-L is in a league of its own, the complexity of the application along with the new PSM data is July could lend to the Oral presentation being needed to hash the questions and concerns?? Just dont know of course. But why no Oral meeting till now, I would think it has to do with the PSM Data?? PSM data was never part of the application, at least it could not have been cause it just came out in July 2026

$NWBO I had AI go through all my CHM Meeting files from 2023-2026 looking for comparisons of this statement in every CHM meeting file "The Commission advised that the concerns had not been adequately addressed and the applicants should be invited to address these concerns in oral representations to the Commission." Attached are my findings , had 2 oral request in 2023, 5 in 2024, 2 in 2025 and ours in 2026. This information is the best I could come with with based on what CHM meetings release to the public and trying to piece together what was approved afterwards.